| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC2322 |
| Trial ID | NCT04287660 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA CAR-T cells |
| Co-treatment | clarithromycin, lenalidomide, dexamethasone |
| Phase | Phase3 |
| Recruitment status | Recruiting |
| Title | Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients |
| Year | 2017 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Soochow University |
| Other ID(s) | BiRd-01 |
| Cohort 1 | |||||||||
|
|||||||||